IMS 3 Trial of Mechanical Embolectomy in Stroke Stopped
The Interventional Management of Stroke 3 (IMS 3) trial, which was comparing intravenous tissue plasminogen activator (tPA) alone with combination tPA and intra-arterial therapy using intra-arterial tPA or mechanical thrombectomy in stroke patients, has suspended enrollment after crossing a prespecified interim analysis threshold.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.